Broadfin Capital’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-144,334
| Closed | -$3.64M | – | 72 |
|
|
2016
Q3 | $3.64M | Hold |
144,334
| – | – | 0.33% | 56 |
|
|
2016
Q2 | $3.57M | Hold |
144,334
| – | – | 0.35% | 51 |
|
|
2016
Q1 | $4.18M | Hold |
144,334
| – | – | 0.4% | 49 |
|
|
2015
Q4 | $5.36M | Hold |
144,334
| – | – | 0.33% | 58 |
|
|
2015
Q3 | $7.03M | Sell |
144,334
-26,973
| -16% | -$1.31M | 0.39% | 53 |
|
|
2015
Q2 | $11.8M | Sell |
171,307
-131,250
| -43% | -$9.05M | 0.63% | 39 |
|
|
2015
Q1 | $10.8M | Buy |
302,557
+79,580
| +36% | +$2.85M | 0.84% | 32 |
|
|
2014
Q4 | $2.82M | Buy |
222,977
+60,274
| +37% | +$762K | 0.25% | 66 |
|
|
2014
Q3 | $2.5M | Buy |
162,703
+66,912
| +70% | +$1.03M | 0.26% | 65 |
|
|
2014
Q2 | $2.6M | Hold |
95,791
| – | – | 0.25% | 65 |
|
|
2014
Q1 | $2.57M | Hold |
95,791
| – | – | 0.25% | 77 |
|
|
2013
Q4 | $2.35M | Buy |
95,791
+6,729
| +8% | +$165K | 0.31% | 51 |
|
|
2013
Q3 | $2.86M | Buy |
89,062
+23,437
| +36% | +$754K | 0.51% | 43 |
|
|
2013
Q2 | $1.95M | Buy |
+65,625
| New | +$1.95M | 0.38% | 43 |
|